Clinical trials
Phase 1/2 Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2016 | 6 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Zhejiang University | 3 |
| National University Hospital, Singapore | 2 |
| Scandion Oncology A/S | 2 |
| Shenzhen University General Hospital | 2 |
| Acibadem University | 1 |
| Arno Therapeutics | 1 |
| Aronex Pharmaceuticals | 1 |
| Asclepius Technology Company Group (Suzhou) Co., Ltd. | 1 |
| Beijing Immunochina Medical Science & Technology Co., Ltd. | 1 |
| Butantan Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 53 |
| Neoplasm Metastasis | 5 |
| Colorectal Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Glioblastoma | 2 |
| Lymphoma | 2 |
| Lymphoma, Mantle-Cell | 2 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.